42 Years of Care and Ensuring No One Fights Alone!

Identify biomarkers for visual restoration strategies in Neurofibromatosis Type 1 optic pathway glioma patients.


This study is seeking to learn how different eye tests and devices can help understand vision in patients with NF1, including how vision loss might show up on different eye imaging devices that measure the nerves or the blood vessels of the eye. The study aims to understand the mechanisms of vision loss caused by neurofibromatosis type 1 (NF1)-associated optic pathway gliomas, or NF1-OPGs. Subjects eight years and older with NF1 are eligible to enroll.

<< Search Our Articles

Get the Latest NF News & Updates

Sign up to be notified of new posts to our website.


Visit Us
Follow Me
Tweet
Share